Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma

Susan Y. Wu,Penny Q. Fang, Ethan B. Wang,Sairah Ahmed,Madeleine Duvic,Preetesh Jain,Luis E. Malpica Castillo,Ranjit Nair,Raphael E. Steiner,Paolo Strati,Auris O. Huen,Swaminathan P. Iyer,Chelsea C. Pinnix,Bouthaina S. Dabaja,Jillian R. Gunther

Advances in Radiation Oncology（2023）

引用 0|浏览19

暂无评分

摘要

Our analysis demonstrates that the combination of BV and RT is well tolerated, though care should be taken during RT planning to reduce the risk of HT. This combination can be considered for patients in need of both local and systemic disease control.

查看译文

关键词

brentuximab vedotin,lymphoma,concurrent radiation therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要